Author - Ziad

The Luminox XCOR 5261 Chronograph wants to send you (and your wrist) to space

Space, the final frontier. These are the voyages of the starship Your Wrist, whose bold 80+ year mission is to help you carry grocery bags and wear watches like the Luminox XCOR 5261 Chronograph. This unique automatic chronograph from a watchmaker most known for brightly luminous and rugged timepieces, is an homage to spaceflight and looks pretty darn cool. Read more >>

Corbus Pharmaceuticals Announces Completion of Phase 2 Study of Resunab for Systemic Sclerosis

Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has completed the Phase 2 study evaluating Resunab for the treatment of diffuse cutaneous systemic sclerosis (“systemic sclerosis”). Corbus expects to report topline data from this study in the fourth quarter of 2016. Read more >>

Blind WI mom tries on glasses to see, hopes to read to kids

A mother in Wisconsin hopes to one day be able to read to her children. Right now, it’s difficult for her to do that since she is legally blind.
Stephanie Geiger from Grand Chute was diagnosed with Cone Rod Dystrophy at the age of 24. It’s difficult for her to see depth perception, certain colors, and details.
Recently, she got to try out eSight eyewear which uses high optics and resolution procession to improve eye sight. […]

Hot Biotech Stocks To Watch Right Now: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (CRBP) a clinical stage drug development company targeting rare, chronic and serious inflammatory and fibrotic diseases, announced that Professor Derek Gilroy, Ph.D. presented data on the effects of Resunab in a model of inflammation in healthy volunteers on September 28, 2016. The presentation was made at the 6th European Workshop on Lipid Mediators at Goethe University in Frankfurt am Main, Germany. Read more >>